APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liraglutide

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

Selected research

Industry Growth & Trends

Global Liraglutide Industry Growth and Trends Forecast to 2032

20 December 202592 pages

Choose your research edition.

Industry ResearchLiraglutide Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Liraglutide Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Liraglutide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liraglutide Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Liraglutide Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

The global Liraglutide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Liraglutide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

Read the full market overview

The Europe market for Liraglutide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

The Asia Pacific market for Liraglutide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Liraglutide include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide and AmbioPharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Liraglutide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Liraglutide market size, estimates, and forecasts are presented in terms of sales volume (K MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Liraglutide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Liraglutide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Liraglutide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Liraglutide Market by Company

HEC Pharm

Bachem

Bharat Pharmaceuticals

Kingpep Biotechnology

Shenzhen JYMed Technology

Wuxi Asiapeptide

AmbioPharm

Liraglutide Segment by Type

Pills

Liquid

Liraglutide Segment by Application

Hospital

Drug Store

Liraglutide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liraglutide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liraglutide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liraglutide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Liraglutide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Liraglutide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pills Table 2. Major Company of Liquid Table 3. Global Liraglutide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Liraglutide Sales by Type (2021-2026) & (K MT) Table 5. Global Liraglutide Sales Market Share in Volume by Type (2021-2026) Table 6. Global Liraglutide Sales by Type (2021-2026) & (US$ Million) Table 7. Global Liraglutide Sales Market Share in Value by Type (2021-2026) Table 8. Global Liraglutide Price by Type (2021-2026) & (USD/MT) Table 9. Global Liraglutide Sales by Type (2027-2032) & (K MT) Table 10. Global Liraglutide Sales Market Share in Volume by Type (2027-2032) Table 11. Global Liraglutide Sales by Type (2027-2032) & (US$ Million) Table 12. Global Liraglutide Sales Market Share in Value by Type (2027-2032) Table 13. Global Liraglutide Price by Type (2027-2032) & (USD/MT) Table 14. North America Liraglutide Sales by Type (2021-2026) & (K MT) Table 15. North America Liraglutide Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Liraglutide Sales by Type (2021-2026) & (K MT) Table 17. Europe Liraglutide Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Liraglutide Sales by Type (2021-2026) & (K MT) Table 19. Asia-Pacific Liraglutide Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Liraglutide Sales by Type (2021-2026) & (K MT) Table 21. Latin America Liraglutide Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Liraglutide Sales by Type (2021-2026) & (K MT) Table 23. Middle East and Africa Liraglutide Sales by Type (2021-2026) & (US$ Million) Table 24. Liraglutide Industry Trends Table 25. Liraglutide Industry Drivers Table 26. Liraglutide Industry Opportunities and Challenges Table 27. Liraglutide Industry Restraints Table 28. Global Liraglutide Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Liraglutide Revenue Market Share by Company (2021-2026) Table 30. Global Liraglutide Sales by Company (2021-2026) & (K MT) Table 31. Global Liraglutide Sales Share by Company (2021-2026) Table 32. Global Liraglutide Market Price by Company (2021-2026) & (USD/MT) Table 33. Global Liraglutide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Liraglutide Major Company Production Sites and Headquarters Table 35. Global Liraglutide Company, Product Type & Application Table 36. Global Liraglutide Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Liraglutide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Liraglutide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Liraglutide Sales by Region (2021-2026) & (K MT) Table 41. Global Liraglutide Sales Market Share in Volume by Region (2021-2026) Table 42. Global Liraglutide Sales by Region (2021-2026) & (US$ Million) Table 43. Global Liraglutide Sales Market Share in Value by Region (2021-2026) Table 44. Global Liraglutide Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 45. Global Liraglutide Sales by Region (2027-2032) & (K MT) Table 46. Global Liraglutide Sales Market Share in Volume by Region (2027-2032) Table 47. Global Liraglutide Sales by Region (2027-2032) & (US$ Million) Table 48. Global Liraglutide Sales Market Share in Value by Region (2027-2032) Table 49. Global Liraglutide Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2027-2032) Table 50. Global Liraglutide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Liraglutide Sales by Application (2021-2026) & (K MT) Table 52. Global Liraglutide Sales Market Share in Volume by Application (2021-2026) Table 53. Global Liraglutide Sales by Application (2021-2026) & (US$ Million) Table 54. Global Liraglutide Sales Market Share in Value by Application (2021-2026) Table 55. Global Liraglutide Price by Application (2021-2026) & (USD/MT) Table 56. Global Liraglutide Sales by Application (2027-2032) & (K MT) Table 57. Global Liraglutide Sales Market Share in Volume by Application (2027-2032) Table 58. Global Liraglutide Sales by Application (2027-2032) & (US$ Million) Table 59. Global Liraglutide Sales Market Share in Value by Application (2027-2032) Table 60. Global Liraglutide Price by Application (2027-2032) & (USD/MT) Table 61. North America Liraglutide Sales by Application (2021-2026) & (K MT) Table 62. North America Liraglutide Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Liraglutide Sales by Application (2021-2026) & (K MT) Table 64. Europe Liraglutide Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Liraglutide Sales by Application (2021-2026) & (K MT) Table 66. Asia-Pacific Liraglutide Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Liraglutide Sales by Application (2021-2026) & (K MT) Table 68. Latin America Liraglutide Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Liraglutide Sales by Application (2021-2026) & (K MT) Table 70. Middle East and Africa Liraglutide Sales by Application (2021-2026) & (US$ Million) Table 71. HEC Pharm Company Information Table 72. HEC Pharm Business Overview Table 73. HEC Pharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 74. HEC Pharm Liraglutide Product Portfolio Table 75. HEC Pharm Recent Development Table 76. Bachem Company Information Table 77. Bachem Business Overview Table 78. Bachem Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 79. Bachem Liraglutide Product Portfolio Table 80. Bachem Recent Development Table 81. Bharat Pharmaceuticals Company Information Table 82. Bharat Pharmaceuticals Business Overview Table 83. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 84. Bharat Pharmaceuticals Liraglutide Product Portfolio Table 85. Bharat Pharmaceuticals Recent Development Table 86. Kingpep Biotechnology Company Information Table 87. Kingpep Biotechnology Business Overview Table 88. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 89. Kingpep Biotechnology Liraglutide Product Portfolio Table 90. Kingpep Biotechnology Recent Development Table 91. Shenzhen JYMed Technology Company Information Table 92. Shenzhen JYMed Technology Business Overview Table 93. Shenzhen JYMed Technology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 94. Shenzhen JYMed Technology Liraglutide Product Portfolio Table 95. Shenzhen JYMed Technology Recent Development Table 96. Wuxi Asiapeptide Company Information Table 97. Wuxi Asiapeptide Business Overview Table 98. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 99. Wuxi Asiapeptide Liraglutide Product Portfolio Table 100. Wuxi Asiapeptide Recent Development Table 101. AmbioPharm Company Information Table 102. AmbioPharm Business Overview Table 103. AmbioPharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 104. AmbioPharm Liraglutide Product Portfolio Table 105. AmbioPharm Recent Development Table 106. North America Liraglutide Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 107. North America Liraglutide Sales by Country (2021-2026) & (K MT) Table 108. North America Liraglutide Sales Market Share by Country (2021-2026) Table 109. North America Liraglutide Sales Forecast by Country (2027-2032) & (K MT) Table 110. North America Liraglutide Sales Market Share Forecast by Country (2027-2032) Table 111. North America Liraglutide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Liraglutide Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Liraglutide Market Share by Country (2021-2026) Table 114. North America Liraglutide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Liraglutide Market Share Forecast by Country (2027-2032) Table 116. Europe Liraglutide Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 117. Europe Liraglutide Sales by Country (2021-2026) & (K MT) Table 118. Europe Liraglutide Sales Market Share by Country (2021-2026) Table 119. Europe Liraglutide Sales Forecast by Country (2027-2032) & (K MT) Table 120. Europe Liraglutide Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Liraglutide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Liraglutide Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Liraglutide Market Share by Country (2021-2026) Table 124. Europe Liraglutide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Liraglutide Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Liraglutide Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Liraglutide Sales by Country (2021-2026) & (K MT) Table 128. Asia-Pacific Liraglutide Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Liraglutide Sales Forecast by Country (2027-2032) & (K MT) Table 130. Asia-Pacific Liraglutide Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Liraglutide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Liraglutide Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Liraglutide Market Share by Country (2021-2026) Table 134. Asia-Pacific Liraglutide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Liraglutide Market Share Forecast by Country (2027-2032) Table 136. Latin America Liraglutide Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 137. Latin America Liraglutide Sales by Country (2021-2026) & (K MT) Table 138. Latin America Liraglutide Sales Market Share by Country (2021-2026) Table 139. Latin America Liraglutide Sales Forecast by Country (2027-2032) & (K MT) Table 140. Latin America Liraglutide Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Liraglutide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Liraglutide Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Liraglutide Market Share by Country (2021-2026) Table 144. Latin America Liraglutide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Liraglutide Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Liraglutide Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Liraglutide Sales by Country (2021-2026) & (K MT) Table 148. Middle East and Africa Liraglutide Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Liraglutide Sales Forecast by Country (2027-2032) & (K MT) Table 150. Middle East and Africa Liraglutide Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Liraglutide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Liraglutide Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Liraglutide Market Share by Country (2021-2026) Table 154. Middle East and Africa Liraglutide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Liraglutide Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Liraglutide Distributors List Table 159. Liraglutide Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Liraglutide Image Figure 2. Global Liraglutide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liraglutide Market Size (2021-2032) & (US$ Million) Figure 4. Global Liraglutide Sales (2021-2032) & (K MT) Figure 5. Pills Image Figure 6. Global Pills Sales YoY Growth (2021-2032) & (K MT) Figure 7. Liquid Image Figure 8. Global Liquid Sales YoY Growth (2021-2032) & (K MT) Figure 9. Global Liraglutide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Liraglutide Market Share by Type 2025 VS 2032 Figure 11. North America Liraglutide Sales Market Share in Volume by Type in 2025 Figure 12. North America Liraglutide Sales Market Share in Value by Type in 2025 Figure 13. Europe Liraglutide Sales Market Share in Volume by Type in 2025 Figure 14. Europe Liraglutide Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Liraglutide Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Liraglutide Sales Market Share in Value by Type in 2025 Figure 17. Latin America Liraglutide Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Liraglutide Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Liraglutide Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Liraglutide Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Liraglutide Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K MT) Figure 25. Drug Store Image Figure 26. Global Drug Store Sales YoY Growth (2021-2032) & (K MT) Figure 27. Global Liraglutide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Liraglutide Market Share by Application 2025 VS 2032 Figure 29. North America Liraglutide Sales Market Share in Volume by Application in 2025 Figure 30. North America Liraglutide Sales Market Share in Value by Application in 2025 Figure 31. Europe Liraglutide Sales Market Share in Volume by Application in 2025 Figure 32. Europe Liraglutide Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Liraglutide Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Liraglutide Sales Market Share in Value by Application in 2025 Figure 35. Latin America Liraglutide Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Liraglutide Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Liraglutide Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Liraglutide Sales Market Share in Value by Application in 2025 Figure 39. North America Liraglutide Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 40. North America Liraglutide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Liraglutide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Liraglutide Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Liraglutide Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 44. Europe Liraglutide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Liraglutide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Liraglutide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Liraglutide Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 48. Asia-Pacific Liraglutide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Liraglutide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Liraglutide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Liraglutide Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 52. Latin America Liraglutide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Liraglutide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Liraglutide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Liraglutide Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 56. Middle East and Africa Liraglutide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Liraglutide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Liraglutide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Liraglutide Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Liraglutide Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Pills
  • Liquid
Applications
  • Hospital
  • Drug Store
Companies covered
  • HEC Pharm
  • Bachem
  • Bharat Pharmaceuticals
  • Kingpep Biotechnology
  • Shenzhen JYMed Technology
  • Wuxi Asiapeptide
  • AmbioPharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Liraglutide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Liraglutide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Liraglutide Market by Type
  6. 1.3.1 Pills
  7. 1.3.2 Liquid
  8. 1.4 Global Liraglutide Market Size by Type
  9. 1.4.1 Global Liraglutide Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Liraglutide Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Liraglutide Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Liraglutide Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Liraglutide Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Liraglutide Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Liraglutide Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Liraglutide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Liraglutide Industry Trends
  2. 2.2 Liraglutide Industry Drivers
  3. 2.3 Liraglutide Industry Opportunities and Challenges
  4. 2.4 Liraglutide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Liraglutide Revenue (2021-2026)
  2. 3.2 Global Top Players by Liraglutide Sales (2021-2026)
  3. 3.3 Global Top Players by Liraglutide Price (2021-2026)
  4. 3.4 Global Liraglutide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Liraglutide Major Company Production Sites & Headquarters
  6. 3.6 Global Liraglutide Company, Product Type & Application
  7. 3.7 Global Liraglutide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Liraglutide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Liraglutide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Liraglutide Tier 1, Tier 2, and Tier 3
4 Liraglutide Regional Status and Outlook
  1. 4.1 Global Liraglutide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Liraglutide Historic Market Size by Region
  3. 4.2.1 Global Liraglutide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Liraglutide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Liraglutide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Liraglutide Forecasted Market Size by Region
  7. 4.3.1 Global Liraglutide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Liraglutide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Liraglutide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Liraglutide by Application
  1. 5.1 Liraglutide Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Liraglutide Market Size by Application
  5. 5.2.1 Global Liraglutide Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Liraglutide Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Liraglutide Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Liraglutide Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Liraglutide Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Liraglutide Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Liraglutide Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Liraglutide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 HEC Pharm
  2. 6.1.1 HEC Pharm Company Information
  3. 6.1.2 HEC Pharm Business Overview
  4. 6.1.3 HEC Pharm Liraglutide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 HEC Pharm Liraglutide Product Portfolio
  6. 6.1.5 HEC Pharm Recent Developments
  7. 6.2 Bachem
  8. 6.2.1 Bachem Company Information
  9. 6.2.2 Bachem Business Overview
  10. 6.2.3 Bachem Liraglutide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bachem Liraglutide Product Portfolio
  12. 6.2.5 Bachem Recent Developments
  13. 6.3 Bharat Pharmaceuticals
  14. 6.3.1 Bharat Pharmaceuticals Company Information
  15. 6.3.2 Bharat Pharmaceuticals Business Overview
  16. 6.3.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bharat Pharmaceuticals Liraglutide Product Portfolio
  18. 6.3.5 Bharat Pharmaceuticals Recent Developments
  19. 6.4 Kingpep Biotechnology
  20. 6.4.1 Kingpep Biotechnology Company Information
  21. 6.4.2 Kingpep Biotechnology Business Overview
  22. 6.4.3 Kingpep Biotechnology Liraglutide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kingpep Biotechnology Liraglutide Product Portfolio
  24. 6.4.5 Kingpep Biotechnology Recent Developments
  25. 6.5 Shenzhen JYMed Technology
  26. 6.5.1 Shenzhen JYMed Technology Company Information
  27. 6.5.2 Shenzhen JYMed Technology Business Overview
  28. 6.5.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shenzhen JYMed Technology Liraglutide Product Portfolio
  30. 6.5.5 Shenzhen JYMed Technology Recent Developments
  31. 6.6 Wuxi Asiapeptide
  32. 6.6.1 Wuxi Asiapeptide Company Information
  33. 6.6.2 Wuxi Asiapeptide Business Overview
  34. 6.6.3 Wuxi Asiapeptide Liraglutide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Wuxi Asiapeptide Liraglutide Product Portfolio
  36. 6.6.5 Wuxi Asiapeptide Recent Developments
  37. 6.7 AmbioPharm
  38. 6.7.1 AmbioPharm Company Information
  39. 6.7.2 AmbioPharm Business Overview
  40. 6.7.3 AmbioPharm Liraglutide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AmbioPharm Liraglutide Product Portfolio
  42. 6.7.5 AmbioPharm Recent Developments
7 North America by Country
  1. 7.1 North America Liraglutide Sales by Country
  2. 7.1.1 North America Liraglutide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Liraglutide Sales by Country (2021-2026)
  4. 7.1.3 North America Liraglutide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Liraglutide Market Size by Country
  6. 7.2.1 North America Liraglutide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Liraglutide Market Size by Country (2021-2026)
  8. 7.2.3 North America Liraglutide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Liraglutide Sales by Country
  2. 8.1.1 Europe Liraglutide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Liraglutide Sales by Country (2021-2026)
  4. 8.1.3 Europe Liraglutide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Liraglutide Market Size by Country
  6. 8.2.1 Europe Liraglutide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Liraglutide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Liraglutide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Liraglutide Sales by Country
  2. 9.1.1 Asia-Pacific Liraglutide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Liraglutide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Liraglutide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Liraglutide Market Size by Country
  6. 9.2.1 Asia-Pacific Liraglutide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Liraglutide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Liraglutide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Liraglutide Sales by Country
  2. 10.1.1 South America Liraglutide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Liraglutide Sales by Country (2021-2026)
  4. 10.1.3 South America Liraglutide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Liraglutide Market Size by Country
  6. 10.2.1 South America Liraglutide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Liraglutide Market Size by Country (2021-2026)
  8. 10.2.3 South America Liraglutide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Liraglutide Sales by Country
  2. 11.1.1 Middle East and Africa Liraglutide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Liraglutide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Liraglutide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Liraglutide Market Size by Country
  6. 11.2.1 Middle East and Africa Liraglutide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Liraglutide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Liraglutide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Liraglutide Value Chain Analysis
  2. 12.1.1 Liraglutide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Liraglutide Production Mode & Process
  7. 12.2 Liraglutide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Liraglutide Distributors
  10. 12.2.3 Liraglutide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst